Ramucirumab as First-Line Therapy in Combination with Cisplatin and Fluoropyrimidine in Patients with Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma (RAINFALL): A Global, Randomised, Double-Blinded, Placebo-Controlled, Phase 3 Trial-Reference-Cited by-同舟云学术

Ramucirumab as First-Line Therapy in Combination with Cisplatin and Fluoropyrimidine in Patients with Metastatic Gastric or Gastro-Oesophageal Junction Adenocarcinoma (RAINFALL): A Global, Randomised, Double-Blinded, Placebo-Controlled, Phase 3 Trial

Published:2018 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Fuchs Charles,Shitara Kohei,Di Bartolomeo Maria,Lonardi Sara,Al-Batran Salah-Eddin,Van Cutsem Eric,Ilson David H.,Alsina Maria,Chau Ian,Lacy Jill,Ducreux Michel,Mendez Guillermo Ariel,Alavez Alejandro Molina,Takahari Daisuke,Mansoor Wasat,Enzinger Peter,Gorbounova Vera,Wainberg Zev A.,Hegewisch-Becker Susanna,Ferry David,Lin Ji,Carlesi Roberto,Das Mayukh,Shah Manish A.,Study Group RAINFALL

Publisher

Elsevier BV

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in targeted therapy for gastric cancer based on tumor driver genes;Journal of Zhejiang University (Medical Sciences);2024-02-01

2. Chemotherapeutic Drugs Endow Gastric Cancer Mesenchymal Stem Cells with Stronger Tumor-Promoting Ability;Journal of Environmental Pathology, Toxicology and Oncology;2024

3. First-Line Systemic Therapy Outcomes in Western Population with Locally Advanced and Metastatic Gastric Cancer—A Systematic Review;Gastroenterology Insights;2023-11-01

4. Research on the Correlation between Advanced Gastric Cancer Molecule Molecular Targeted and Immune Therapy;Advances in Clinical Medicine;2022

5. Nivolumab as a representative of immune checkpoint inhibitors in late-line treatment for disseminated gastric cancer;Meditsinskiy sovet = Medical Council;2021-08-07